Both in Biotechnology
Tessera Defense and Homeland Security vs Silexion Therapeutics
Over the past year HLSQ returned −87.5% and SLXN returned −58.5%; their daily moves had a correlation of 0.24.
HLSQ −87.5% SLXN −58.5%Growth of $1, one year, split-adjusted
| Metric | HLSQ | SLXN |
|---|---|---|
| Price | $0.1585 | $0.1482 |
| Market cap | $3.3M | $2.1M |
| Today | −7.74% | +2.07% |
| 1 month | −56.0% | −43.0% |
| 6 months | — | −97.7% |
| Year to date | — | −99.2% |
| 1 year | — | −99.6% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | — | — |
| Dividend yield | — | — |
| Volatility (60d) | — | 240.6% |
| Short % of float | 3.6% | 3.7% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).